Infectious Disease Point of Care Diagnostics Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : December 2020 Pages : 154 Category: Chemicals & Nanomaterials Report Code : CM1214106
Infectious Disease Point of Care Diagnostics MarketBy Type (Over-the-counter (OTC) Testing Kits, Prescription-based Testing Kits) and Application (Bacterial Infections, Fungal Infection, Virus Infection, Cardiovascular Infection, Gastrointestinal Infection, Sexually Transmitted Disease (STD) Infection, Central Nervous System Infection, Other)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Infectious Disease Point of Care Diagnostics Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results. Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites. Instant diagnosis of infectious diseases can improve disease management and detection, reducing the time between disease testing and diagnosis of infection.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Infectious Disease Point of Care Diagnostics Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Abbott
- Siemens
- GE Healthcare
- Accriva
- Terumo
- BioMerieux
- Diasorin
- Roche
- Danaher Corporation
- BD
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Infectious Disease Point of Care Diagnostics Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Over-the-counter (OTC) Testing Kits
o Prescription-based Testing Kits
· Infectious Disease Point of Care Diagnostics Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Bacterial Infections
o Fungal Infection
o Virus Infection
o Cardiovascular Infection
o Gastrointestinal Infection
o Sexually Transmitted Disease (STD) Infection
o Central Nervous System Infection
o Other
· Infectious Disease Point of Care Diagnostics Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Abbott
o Siemens
o GE Healthcare
o Accriva
o Terumo
o BioMerieux
o Diasorin
o Roche
o Danaher Corporation
o BD
· Infectious Disease Point of Care Diagnostics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Infectious Disease Point of Care Diagnostics Market, By Country
o U.S. Infectious Disease Point of Care Diagnostics Market
o Canada Infectious Disease Point of Care Diagnostics Market
o Mexico Infectious Disease Point of Care Diagnostics Market
o Europe
§ Europe Infectious Disease Point of Care Diagnostics Market, By Country
· Germany Infectious Disease Point of Care Diagnostics Market
o UK Infectious Disease Point of Care Diagnostics Market
o France Infectious Disease Point of Care Diagnostics Market
o RussiaInfectious Disease Point of Care Diagnostics Market
o Italy Infectious Disease Point of Care Diagnostics Market
o Rest of Europe Infectious Disease Point of Care Diagnostics Market
o Asia-Pacific
§ Asia-Pacific Infectious Disease Point of Care Diagnostics Market, By Country
o ChinaInfectious Disease Point of Care Diagnostics Market
o Japan Infectious Disease Point of Care Diagnostics Market
o South KoreaInfectious Disease Point of Care Diagnostics Market
o India Infectious Disease Point of Care Diagnostics Market
o Southeast AsiaInfectious Disease Point of Care Diagnostics Market
o Rest of Asia-Pacific Infectious Disease Point of Care Diagnostics Market
o South America
§ South AmericaInfectious Disease Point of Care Diagnostics Market
o Brazil Infectious Disease Point of Care Diagnostics Market
o ArgentinaInfectious Disease Point of Care Diagnostics Market
o ColumbiaInfectious Disease Point of Care Diagnostics Market
o Rest of South America Infectious Disease Point of Care Diagnostics Market
o Middle East and Africa
§ Middle East and AfricaInfectious Disease Point of Care Diagnostics Market
o Saudi ArabiaInfectious Disease Point of Care Diagnostics Market
o UAEInfectious Disease Point of Care Diagnostics Market
o EgyptInfectious Disease Point of Care Diagnostics Market
o NigeriaInfectious Disease Point of Care Diagnostics Market
o South Africa Infectious Disease Point of Care Diagnostics Market
o Rest of MEA Infectious Disease Point of Care Diagnostics Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Infectious Disease Point Of Care Diagnostics Market, By Type
5.1. Introduction
5.2. Global Infectious Disease Point Of Care Diagnostics Revenue and Market Share by Type (2017-2021)
5.2.1. Global Infectious Disease Point Of Care Diagnostics Revenue and Revenue Share by Type (2017-2021)
5.3. Over-the-counter (OTC) Testing Kits
5.3.1. Global Over-the-counter (OTC) Testing Kits Revenue and Growth Rate (2017-2021)
5.4. Prescription-based Testing Kits
5.4.1. Global Prescription-based Testing Kits Revenue and Growth Rate (2017-2021)
6. Infectious Disease Point Of Care Diagnostics Market, By Application
6.1. Introduction
6.2. Global Infectious Disease Point Of Care Diagnostics Revenue and Market Share by Application (2017-2021)
6.2.1. Global Infectious Disease Point Of Care Diagnostics Revenue and Revenue Share by Application (2017-2021)
6.3. Bacterial Infections
6.3.1. Global Bacterial Infections Revenue and Growth Rate (2017-2021)
6.4. Fungal Infection
6.4.1. Global Fungal Infection Revenue and Growth Rate (2017-2021)
6.5. Virus Infection
6.5.1. Global Virus Infection Revenue and Growth Rate (2017-2021)
6.6. Cardiovascular Infection
6.6.1. Global Cardiovascular Infection Revenue and Growth Rate (2017-2021)
6.7. Gastrointestinal Infection
6.7.1. Global Gastrointestinal Infection Revenue and Growth Rate (2017-2021)
6.8. Sexually Transmitted Disease (STD) Infection
6.8.1. Global Sexually Transmitted Disease (STD) Infection Revenue and Growth Rate (2017-2021)
6.9. Central Nervous System Infection
6.9.1. Global Central Nervous System Infection Revenue and Growth Rate (2017-2021)
6.10. Other
6.10.1. Global Other Revenue and Growth Rate (2017-2021)
7. Infectious Disease Point Of Care Diagnostics Market, By Region
7.1. Introduction
7.2. Global Infectious Disease Point Of Care Diagnostics Revenue and Market Share by Regions
7.2.1. Global Infectious Disease Point Of Care Diagnostics Revenue by Regions (2017-2021)
7.3. North America Infectious Disease Point Of Care Diagnostics by Countries
7.3.1. North America Infectious Disease Point Of Care Diagnostics Revenue and Growth Rate (2017-2021)
7.3.2. North America Infectious Disease Point Of Care Diagnostics Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Infectious Disease Point Of Care Diagnostics by Countries
7.4.1. Europe Infectious Disease Point Of Care Diagnostics Revenue and Growth Rate (2017-2021)
7.4.2. Europe Infectious Disease Point Of Care Diagnostics Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Infectious Disease Point Of Care Diagnostics by Countries
7.5.1. Asia-Pacific Infectious Disease Point Of Care Diagnostics Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Infectious Disease Point Of Care Diagnostics Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Infectious Disease Point Of Care Diagnostics by Countries
7.6.1. South America Infectious Disease Point Of Care Diagnostics Revenue and Growth Rate (2017-2021)
7.6.2. South America Infectious Disease Point Of Care Diagnostics Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Infectious Disease Point Of Care Diagnostics by Countries
7.7.1. Middle East and Africa Infectious Disease Point Of Care Diagnostics Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Infectious Disease Point Of Care Diagnostics Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Abbott
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Siemens
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. GE Healthcare
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Accriva
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Terumo
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. BioMerieux
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Diasorin
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Roche
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Danaher Corporation
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. BD
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.1. Global Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Infectious Disease Point Of Care Diagnostics Market Forecast by Regions (2022-2027)
9.2.1. North America Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.1.1. United States Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.1.2. Canada Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.1.3. Mexico Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.2. Europe Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.2.1. Germany Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.2.2. France Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.2.3. UK Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.2.4. Russia Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.2.5. Italy Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.3. Asia-Pacific Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.3.1. China Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.3.2. Japan Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.3.3. Korea Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.3.4. India Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.4. South America Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.4.1. Brazil Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.4.2. Argentina Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.4.3. Columbia Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.4.4. Rest of South America Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.5. Middle East and Africa Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.5.3. Egypt Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.5.4. Nigeria Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.5.5. South Africa Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.5.6. Turkey Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Infectious Disease Point Of Care Diagnostics Market Forecast (2022-2027)
9.3. Infectious Disease Point Of Care Diagnostics Market Forecast by Type (2022-2027)
9.3.1. Infectious Disease Point Of Care Diagnostics Forecast by Type (2022-2027)
9.3.2. Infectious Disease Point Of Care Diagnostics Market Share Forecast by Type (2022-2027)
9.4. Infectious Disease Point Of Care Diagnostics Market Forecast by Application (2022-2027)
9.4.1. Infectious Disease Point Of Care Diagnostics Forecast by Application (2022-2027)
9.4.2. Infectious Disease Point Of Care Diagnostics Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Infectious Disease Point Of Care Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Infectious Disease Point Of Care Diagnostics Revenue and Revenue Share by Type (2017-2019)
Figure Global Over-the-counter (OTC) Testing Kits Revenue and Growth Rate (2017-2019)
Figure Global Prescription-based Testing Kits Revenue and Growth Rate (2017-2019)
Table Global Infectious Disease Point Of Care Diagnostics Revenue and Revenue Share by Application (2017-2019)
Figure Global Bacterial Infections Revenue and Growth Rate (2017-2019)
Figure Global Fungal Infection Revenue and Growth Rate (2017-2019)
Figure Global Virus Infection Revenue and Growth Rate (2017-2019)
Figure Global Cardiovascular Infection Revenue and Growth Rate (2017-2019)
Figure Global Gastrointestinal Infection Revenue and Growth Rate (2017-2019)
Figure Global Sexually Transmitted Disease (STD) Infection Revenue and Growth Rate (2017-2019)
Figure Global Central Nervous System Infection Revenue and Growth Rate (2017-2019)
Figure Global Other Revenue and Growth Rate (2017-2019)
Table Global Infectious Disease Point Of Care Diagnostics Revenue by Regions (2017-2019)
Figure North America Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure North America Infectious Disease Point Of Care Diagnostics Revenue and Growth Rate (2017-2019)
Figure North America Infectious Disease Point Of Care Diagnostics by Countries (2017-2019)
Figure North America Infectious Disease Point Of Care Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure United States Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure United States Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Canada Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Mexico Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Europe Infectious Disease Point Of Care Diagnostics Revenue and Growth Rate (2017-2019)
Figure Europe Infectious Disease Point Of Care Diagnostics by Countries (2017-2019)
Figure Europe Infectious Disease Point Of Care Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure Germany Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Germany Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure France Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure UK Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Russia Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Italy Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Rest of Europe Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Asia-Pacific Infectious Disease Point Of Care Diagnostics Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Infectious Disease Point Of Care Diagnostics by Countries (2017-2019)
Figure Asia-Pacific Infectious Disease Point Of Care Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure China Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure China Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Japan Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Korea Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure India Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Southeast Asia Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure South America Infectious Disease Point Of Care Diagnostics Revenue and Growth Rate (2017-2019)
Figure South America Infectious Disease Point Of Care Diagnostics by Countries (2017-2019)
Figure South America Infectious Disease Point Of Care Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Brazil Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Argentina Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Columbia Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Rest of South America Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Middle East and Africa Infectious Disease Point Of Care Diagnostics Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Infectious Disease Point Of Care Diagnostics by Countries (2017-2019)
Figure Middle East and Africa Infectious Disease Point Of Care Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Saudi Arabia Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure United Arab Emirates Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Egypt Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Nigeria Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure South Africa Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Turkey Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Infectious Disease Point Of Care Diagnostics Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Table Abbott Infectious Disease Point Of Care Diagnostics Financial Overview
Table Siemens Infectious Disease Point Of Care Diagnostics Financial Overview
Table GE Healthcare Infectious Disease Point Of Care Diagnostics Financial Overview
Table Accriva Infectious Disease Point Of Care Diagnostics Financial Overview
Table Terumo Infectious Disease Point Of Care Diagnostics Financial Overview
Table BioMerieux Infectious Disease Point Of Care Diagnostics Financial Overview
Table Diasorin Infectious Disease Point Of Care Diagnostics Financial Overview
Table Roche Infectious Disease Point Of Care Diagnostics Financial Overview
Table Danaher Corporation Infectious Disease Point Of Care Diagnostics Financial Overview
Table BD Infectious Disease Point Of Care Diagnostics Financial Overview
Figure Global Infectious Disease Point Of Care Diagnostics Revenue (Millions USD) and Growth Rate (2019-2027)
Table Infectious Disease Point Of Care Diagnostics Market Forecast by Regions (2019-2027)
Figure North America Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure United States Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Canada Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Mexico Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Europe Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Germany Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure France Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure UK Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Russia Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Italy Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Rest of Europe Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Asia-Pacific Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure China Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Japan Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Korea Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure India Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Southeast Asia Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure South America Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Brazil Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Argentina Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Columbia Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Rest of South America Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Middle East and Africa Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Saudi Arabia Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure United Arab Emirates Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Egypt Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Nigeria Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure South Africa Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Turkey Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Infectious Disease Point Of Care Diagnostics Market Forecast (2019-2027)
Figure Global Infectious Disease Point Of Care Diagnostics Forecast by Type (2019-2027)
Figure Global Infectious Disease Point Of Care Diagnostics Market Share Forecast by Type (2019-2027)
Figure Global Infectious Disease Point Of Care Diagnostics Forecast by Type (2019-2027)
Figure Global Infectious Disease Point Of Care Diagnostics Forecast by Application (2019-2027)
Figure Global Infectious Disease Point Of Care Diagnostics Market Share Forecast by Application (2019-2027)
Figure Global Infectious Disease Point Of Care Diagnostics Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|